We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A baby laying down.

No Adverse Health Risks From Steroids Used for Pre-Term Birth, Study Finds

A ginger haired woman leaning over the arm of a chair.

Scientists Identify Brain Circuit That Suppresses Appetite During Nausea

Immunotherapy attacking a cancer cell.

Immunotherapy Combination Approved for Non-Muscle Invasive Bladder Cancer

Psilocybin Shows Promise for Treatment-Resistant Depression – But Is It Safe?

Phage Therapies for Multidrug-Resistant Infections Should Consider Host Response

First Use of CRISPR-Cas9 Gene Editing in Kissing Bugs

News

Spinnovation Receives Good Manufacturing Practices Certification

Certification for testing drug substances and drug products to support market release.

Anti-Diabetic Drug Springs New Hope for Tuberculosis Patients

Drug for treating diabetes can double up as adjunct treatment for tuberculosis.

BioLineRx and Major Global Pharmaceutical Company Form Strategic Collaboration

Global pharmaceutical company makes initial $10 million equity investment in BioLineRx.

Novel Agent Decreases Neuropathic Pain in Patients with Type 2 Diabetes

Promising profile of disease modification and pain reduction leads to proof of concept trials.

Curie-Cancer and GamaMabs Pharma Renew their Research Partnership

Clinical trials are scheduled for 2015 to explore the value of the candidate drug 3C23K in relapsing ovarian cancer.

OHSU and FEI Expand Living Lab with New Equipment for Cancer Research

Installation is part of an expansion of the OHSU/FEI Living Lab for Cell Biology collaboration.

25 Years of Revolutionary Microplate Reader Technology at the LS2

BMG LABTECH exhibits at the biggest Swiss Life Sciences Meeting for the first time.

Reasons for Malaria’s Drug Resistance

Scientists from Nanyang Technological University (NTU) have discovered exactly how the malaria parasite is developing resistance towards the most important front-line drugs used to treat the disease.

Key US Patents Granted for GPCR-Focused Drug Discovery Platform

Structure-based drug discovery platform targets challenging GPCRs linked to human disease.

BioLineRx Presents Multi-Year Clinical Development Plan for BL-8040

Clinical trials in three additional indications for BL-8040 to be initiated in 2015.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter